Reply to Cauwels et al.: Of men, not mice, and inflammation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 34, 2013, Pages

  Shaw Warren, H ^a   Tompkins, Ronald G ^a   Mindrinos, Michael N ^b   Xiao, Wenzhong ^a,b   Davis, Ronald W ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR INHIBITOR;

ANIMAL MODEL; BLOOD CELL; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENTERITIS; HUMAN; IN VITRO STUDY; LETTER; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEPSIS; ANIMAL; FEMALE; GENETICS; GENOMICS; INFLAMMATION; MALE;

MUS;

ANIMALS; FEMALE; GENOMICS; HUMANS; INFLAMMATION; MALE;

EID: 84882796123     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1308943110     Document Type: Letter

References (5)

1. Cauwels A, Vandendriessche B, Brouckaert P (2013) Of mice, men, and inflammation. Proc Natl Acad Sci USA 110:E3150.
2. Seok J, et al.; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program (2013) Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110(9):3507-3512.
3. Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229(4716):869-871.
4. Abraham E, et al. (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351(9107):929-933.
5. Albina JE (1995) On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 58(6): 643-649.